Parabilis Medicines files for 25M share IPO at $17-$19/sh

Chronological Source Flow
Back

AI Fusion Summary

Parabilis Medicines has filed for a U.S. initial public offering, seeking to issue 25 million shares. The company has set a target price range between $17 and $19 per share, aiming to raise approximately $475 million.
Community Comments
Loading updates...
0